SCHEMBL7307452

SCHEMBL7307452

N#Cc1cc2ccccc2c([O])c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.46
CA2 P00918 4/20 0.46
CLK1 P49759 2/20 0.45
DYRK1A Q13627 2/20 0.45
NCOA3 Q9Y6Q9 1/20 0.44
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 5/20 0.41
GAA P10253 3/20 0.40
MEN1 O00255 3/20 0.39
MAPT P10636 3/20 0.39
KMT2A Q03164 3/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
ANPEP P15144 1/20 0.38
MCL1 Q07820 1/20 0.38
PDE9A O76083 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
CLK2 P49760 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28869476 0.82 CLK1 (0.49) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL31457372 0.82 CLK1 (0.49) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL7302966 0.79 CA1 (0.41) CA1CA2IMPDH2IMPDH1
SCHEMBL8955230 0.78 DYRK1A (0.45) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL10829252 0.78 CLK1 (0.45) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL9453843 0.78 CLK1 (0.45) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL3961346 0.78 DYRK1A (0.45) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL11845987 0.78 KDM4E (0.47) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL10338293 0.78 KDM4E (0.59) CA1CA2CLK1DYRK1ANCOA3
SCHEMBL27541400 0.76 KDM4E (0.58) CA1CA2CLK1DYRK1ANCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed